Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
PROHANCE 279,3 mg/ml SOLUCION INYECTABLE
Injection
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- GADOTERIDOL — 0.5 mmol
- Pharmaceutical form Home Med Cabinet grouping
- Injection
- Availability in Spain
- All 5 packs marketed
Packs
PROHANCE 279,3 mg/ml SOLUCION INYECTABLE , 1 vial de 20 ml
1 pcs
National code
Marketed691485PROHANCE 279,3 mg/ml SOLUCION INYECTABLE , 1 vial de 15 ml
1 pcs
National code
Marketed691493PROHANCE 279,3 mg/ml SOLUCION INYECTABLE , 1 vial de 10 ml
1 pcs
National code
Marketed691501PROHANCE 279,3 mg/ml SOLUCION INYECTABLE,1 vial de 100 ml
1 pcs
National code
Marketed731183Strength of this pack 100 ml
PROHANCE 279,3 mg/ml SOLUCION INYECTABLE , 1 vial de 50 ml
1 pcs
National code
Marketed781922
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 60377Official data
- Marketing authorisation holder
- BRACCO INTERNATIONAL B.V.Official data
- Authorised
- Dec 1, 1998Official data
- Authority form code
- 197Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.